We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.97B
AUM Growth
-$227M
Cap. Flow
-$120M
Cap. Flow %
-2.42%
Top 10 Hldgs %
24.91%
Holding
802
New
109
Increased
252
Reduced
267
Closed
54

Top Buys

Rank Stock Value
1
VTR icon
Ventas
VTR
+$29.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$28.3M
3
ECL icon
Ecolab
ECL
+$25.4M
4
MRK icon
Merck
MRK
+$24.7M
5
EW icon
Edwards Lifesciences
EW
+$20.9M

Top Sells

Rank Stock Value
1
NOW icon
ServiceNow
NOW
+$44M
2
SBAC icon
SBA Communications
SBAC
+$43.3M
3
CMG icon
Chipotle Mexican Grill
CMG
+$42M
4
AMTD
TD Ameritrade Holding Corp
AMTD
+$40.5M
5
GILD icon
Gilead Sciences
GILD
+$39.1M

Sector Composition

Rank Sector Weight
1 Healthcare 18.75%
2 Consumer Discretionary 15.42%
3 Technology 15.27%
4 Financials 12.99%
5 Industrials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNI icon
151
Canadian National Railway
CNI
$76.5B
$2.67M 0.05%
42,705
-3,700
-8% -$207K
GIS icon
152
General Mills
GIS
$21.6B
$2.66M 0.05%
41,962
+14
+0% +$814
MRSH
153
Marsh
MRSH
$90.7B
$2.64M 0.05%
43,427
-1,642
-4% -$92K
EQNR icon
154
Equinor
EQNR
$98.6B
$2.64M 0.05%
169,395
-42,940
-20% -$599K
TSM icon
155
TSMC
TSM
$2.22T
$2.59M 0.05%
98,824
+67,650
+217% +$1.58M
BMRN icon
156
BioMarin Pharmaceuticals
BMRN
$12.6B
$2.58M 0.05%
31,312
+8,560
+38% +$696K
IVV icon
157
iShares Core S&P 500 ETF
IVV
$900B
$2.57M 0.05%
12,435
+507
+4% +$99.5K
DEO icon
158
Diageo
DEO
$51.2B
$2.54M 0.05%
23,563
+2,247
+11% +$238K
KO icon
159
Coca-Cola
KO
$383B
$2.51M 0.05%
54,110
+18
+0% +$783
VGK icon
160
Vanguard FTSE Europe ETF
VGK
$31B
$2.48M 0.05%
51,144
+148
+0.3% +$6.92K
WEC icon
161
WEC Energy
WEC
$34.6B
$2.46M 0.05%
41,012
+751
+2% +$42K
BABA icon
162
Alibaba
BABA
$279B
$2.43M 0.05%
30,775
+1,254
+4% +$88.3K
CSCO icon
163
Cisco
CSCO
$442B
$2.43M 0.05%
85,323
+7,354
+9% +$189K
NEOG icon
164
Neogen
NEOG
$2.56B
$2.41M 0.05%
127,621
-51,243
-29% -$976K
MDY icon
165
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.7B
$2.39M 0.05%
9,103
+540
+6% +$131K
EMC
166
DELISTED
EMC CORPORATION
EMC
$2.36M 0.05%
88,418
-10,712
-11% -$271K
GLD icon
167
SPDR Gold Trust
GLD
$154B
$2.35M 0.05%
20,012
+5,573
+39% +$632K
GRFS
168
Grifois
GRFS
$5.32B
$2.35M 0.05%
151,826
-20,226
-12% -$306K
TSLA icon
169
Tesla
TSLA
$1.4T
$2.34M 0.05%
152,925
+65,955
+76% +$868K
RLI icon
170
RLI Corp
RLI
$5.89B
$2.29M 0.05%
68,592
+57,644
+527% +$1.81M
NVS icon
171
Novartis
NVS
$294B
$2.27M 0.05%
34,907
-292
-0.8% -$19.9K
CEB
172
DELISTED
CEB Inc.
CEB
$2.25M 0.05%
34,820
-11,851
-25% -$678K
MJN
173
DELISTED
Mead Johnson Nutrition Company
MJN
$2.25M 0.05%
26,500
-4,830
-15% -$359K
FMX icon
174
Fomento Económico Mexicano
FMX
$41B
$2.2M 0.04%
22,866
+193
+0.9% +$17.6K
LUX
175
DELISTED
Luxottica Group
LUX
$2.18M 0.04%
39,694
-5,772
-13% -$335K
5 6
7
8 9

Similar funds

CAM
Capstone Asset Management Houston, Texas $3.6B AUM 20.22% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
RBC
Ronald Blue & Co Roswell, Georgia $3.1B AUM 12.82% 1-Year Est. Return
TCM
Tetrem Capital Management Winnipeg, Manitoba, Canada $2.29B AUM 16.55% 1-Year Est. Return
HCM
Holland Capital Management Chicago, Illinois $2.28B AUM 23.08% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
AT
Alliance Trust Dundee, Scotland, United Kingdom $1.81B AUM 5.04% 1-Year Est. Return

Geneva Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Geneva Advisors held 802 positions worth $4.97B, down 4.4% from $5.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Advisors's Q1 2016 filing shows 109 new, 252 increased, 267 reduced and 54 closed positions. Its largest new stake was Ventas: 517,036 shares worth $32.6M. The largest sale was ServiceNow, an estimated $44M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Geneva Advisors's largest Q1 2016 buy was Ventas: 517,036 shares worth $32.6M.
  • Geneva Advisors added most to Bristol-Myers Squibb in Q1 2016, an estimated $28.3M increase.
  • Geneva Advisors's biggest Q1 2016 reduction was SBA Communications, cutting an estimated $43.3M.
  • Geneva Advisors fully exited ServiceNow in Q1 2016, selling an estimated $44M.
  • Geneva Advisors's ten largest holdings make up 25% of its $4.97B portfolio in Q1 2016.
  • Geneva Advisors opened 109 new positions and closed 54 in Q1 2016.
  • Geneva Advisors's portfolio value fell 4.4% quarter-over-quarter to $4.97B.

Based on Geneva Advisors's 13F filing for Q1 2016, filed 3 May 2016.